# A Comparative Study of the Effects of QS-M Needle Free Injector and Glargine Pen Subcutaneous Injection of Insulin Glargine on Insulin Use

> **NCT03420040** · NA · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 65 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DEVICE:** QS-M Needle Free Injector
- **DEVICE:** Glargine pen

## Key facts

- **NCT ID:** NCT03420040
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-27
- **Primary completion:** 2018-02-20
- **Final completion:** 2018-04-01
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03420040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03420040, "A Comparative Study of the Effects of QS-M Needle Free Injector and Glargine Pen Subcutaneous Injection of Insulin Glargine on Insulin Use". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03420040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*